Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Kenneth Ataga, MD
Researcher Director
Division of Hematology/Oncology
University of Tennessee Health Science Center
956 Court Avenue
D324 Coleman Building
Memphis, Tennessee, United States
Dr. Ataga’s clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Pharmacologic Therapies for Sickle Cell Disease
+myBinderRelated Content
-
Mandy DavidMandy David is a senior health communica...
-
Adult Sickle Cell Clinic at UAMSThe University of Arkansas for Medical S...
-
Sickle Cell Anemia Foundation of OregonThe Sickle Cell Anemia Foundation of Ore...
-
Wally Smith, MDWally Smith is Professor of Internal Med...
-
A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualizati...BACKGROUND:Vaso-occlusive crisis (VOC) i...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Sickle cell pain in the emergency departmentSickle cell disease is characterized by ...
